KEGG: set:SEN3198
AaeA functions as the membrane fusion protein component of the AaeAB efflux pump system in Salmonella enteritidis PT4. This system is specifically involved in the efflux of aromatic carboxylic acids, particularly p-hydroxybenzoic acid (pHBA). The AaeA subunit works in conjunction with AaeB to form a functional efflux apparatus that spans the bacterial cell envelope.
The physiological role of this system appears to be as a "metabolic relief valve" to alleviate toxic effects of imbalanced metabolism, particularly accumulation of aromatic carboxylic acids that could be detrimental to cellular function. Studies in Escherichia coli have demonstrated that expression of both aaeA and aaeB is necessary and sufficient for protection against pHBA toxicity .
The recombinant production of Salmonella enteritidis PT4 AaeA protein can be successfully achieved using Escherichia coli expression systems. Based on current protocols, the following conditions are recommended:
| Parameter | Recommended Condition |
|---|---|
| Expression System | E. coli |
| Vector Type | pET series with N-terminal His-tag |
| Induction | IPTG (0.5-1.0 mM) |
| Temperature | 25-30°C post-induction |
| Duration | 4-6 hours or overnight at lower temperature |
| Cell Lysis | Sonication or pressure-based disruption |
| Protein Purification | Ni-NTA affinity chromatography |
It is important to note that membrane-associated proteins like AaeA can present challenges during expression and purification. Including mild detergents in the purification buffers may enhance protein solubility and stability .
To maintain the stability and activity of purified recombinant Salmonella enteritidis PT4 AaeA protein, the following storage conditions are recommended:
Primary storage should be at -20°C/-80°C in aliquots to avoid repeated freeze-thaw cycles.
The optimal storage buffer consists of Tris/PBS-based buffer with 6% Trehalose at pH 8.0.
For longer-term storage, adding 5-50% glycerol (final concentration) is recommended, with 50% being the default concentration used in most protocols.
For working stocks, maintain aliquots at 4°C for up to one week.
After reconstitution, the protein should be diluted to 0.1-1.0 mg/mL in deionized sterile water.
These storage recommendations help preserve protein integrity and functional activity for experimental use .
The regulation of aaeA exhibits both similarities and differences between Salmonella enteritidis and Escherichia coli:
In Escherichia coli, the aaeA gene (formerly yhcQ) is part of the aaeXAB operon, which is regulated by the upstream, divergently transcribed aaeR gene encoding a LysR family regulatory protein. This system responds to aromatic carboxylic acids, with p-hydroxybenzoic acid (pHBA) being a primary inducer. Treatment of E. coli with pHBA results in significant upregulation of aaeA .
In Salmonella enteritidis PT4, genomic analysis reveals a similar operon structure, but with potential differences in regulatory mechanisms. While the core components of the efflux system are conserved between the two species, comparative genomic studies suggest variations in regulatory networks. The average nucleotide identity between shared orthologs of Salmonella enteritidis PT4 and Salmonella Typhimurium LT2 is approximately 98.98%, indicating potential functional differences in gene regulation even among Salmonella serovars .
Furthermore, the expression of aaeA in Salmonella enteritidis may be influenced by small regulatory RNAs such as SaaS, which has been shown to modulate the expression of various virulence-associated genes in response to environmental stimuli .
The AaeA protein, as a component of the AaeAB efflux system, potentially contributes to Salmonella enteritidis antimicrobial resistance through several mechanisms:
Direct efflux of antimicrobial compounds: While the AaeAB system primarily extrudes aromatic carboxylic acids, it may have broader substrate specificity that includes certain antimicrobial agents or their metabolites. Studies in E. coli have shown that only a few aromatic carboxylic acids from hundreds of tested compounds were defined as substrates, suggesting specificity but also the possibility of unidentified substrates .
Cross-resistance mechanisms: The upregulation of one efflux system can sometimes confer resistance advantages through general stress response pathways or through compensatory mechanisms affecting other resistance determinants.
Biofilm formation: Efflux pumps, including those involved in metabolite export, have been implicated in biofilm formation, which can enhance antimicrobial resistance through physical barriers and altered metabolic states.
Metabolic adaptation: The "metabolic relief valve" function proposed for the AaeAB system suggests a role in maintaining cellular homeostasis under stress conditions, potentially contributing to survival during antimicrobial exposure.
Research methodologies to investigate these aspects would include gene knockout studies, antimicrobial susceptibility testing of mutant strains, transcriptomic analysis under various stress conditions, and in vitro selection of resistant mutants followed by genomic characterization.
The AaeA protein shows significant conservation across Salmonella serovars, reflecting its important functional role. Comparative genomic analysis indicates:
Sequence conservation: The core domains and functional regions of AaeA are highly conserved across Salmonella enterica subspecies, with particular preservation of transmembrane domains and substrate interaction sites.
Synteny: The genomic organization of the aaeA gene and its associated operon structure is maintained across various Salmonella serovars, including Enteritidis PT4 and Typhimurium LT2. This conservation of synteny suggests functional importance of the efflux system .
Evolutionary stability: Unlike some virulence factors or antibiotic resistance determinants that may show evidence of horizontal gene transfer or rapid evolution, the AaeA protein appears to be part of the ancestral core genome of Salmonella.
Host-adaptation considerations: Interestingly, in host-restricted Salmonella serovars like S. Gallinarum (which has evolved from S. Enteritidis), there is a higher number of pseudogenes compared to broad-host range serovars like S. Enteritidis PT4. While specific data on aaeA pseudogenization in these strains is limited in the provided search results, this pattern suggests potential differential selection pressures on metabolic systems during host adaptation .
To effectively study AaeA interactions with other efflux pump components, particularly AaeB, researchers should consider employing a multi-faceted approach:
Protein-protein interaction studies:
Co-immunoprecipitation (Co-IP) using antibodies against tagged versions of AaeA
Bacterial two-hybrid systems to detect direct interactions
Surface plasmon resonance (SPR) for measuring binding kinetics
Fluorescence resonance energy transfer (FRET) for in vivo interaction studies
Structural biology approaches:
X-ray crystallography of the AaeA protein alone and in complex with AaeB
Cryo-electron microscopy to visualize the entire efflux pump complex
Molecular dynamics simulations to predict interaction domains
NMR spectroscopy for analyzing protein dynamics during substrate binding and transport
Functional genomics:
Site-directed mutagenesis of potential interaction domains
Suppressor mutation analysis to identify compensatory changes
Domain swapping experiments between homologous proteins from different species
Construction of chimeric proteins to identify functional domains
In vivo imaging:
Fluorescent protein fusions to visualize localization and co-localization
Single-molecule tracking to observe dynamics in living cells
Super-resolution microscopy to determine spatial organization of efflux complexes
These methodological approaches, used in combination, would provide comprehensive insights into how AaeA interacts with AaeB and potentially other components to form a functional efflux system in Salmonella enteritidis PT4.
To comprehensively investigate the role of AaeA in Salmonella virulence, researchers should employ a combination of molecular, cellular, and in vivo approaches:
Genetic manipulation:
Construction of clean deletion mutants (ΔaaeA)
Complementation studies with wild-type and mutated versions of aaeA
Conditional expression systems to control AaeA levels during specific infection stages
CRISPR-Cas9 genome editing for precise modifications
In vitro infection models:
Epithelial cell invasion assays using Caco-2 or similar intestinal epithelial cell lines
Macrophage survival assays using RAW 264.7 cells to assess intracellular persistence
Co-culture systems with multiple cell types to better simulate host tissue environments
Simulated intestinal environment (SIE) systems to study environmental regulation
In vivo infection models:
BALB/c mouse model of systemic salmonellosis
Streptomycin-pretreated mouse model for studying gastrointestinal colonization
Competitive index assays comparing wild-type and ΔaaeA strains in mixed infections
Tissue-specific bacterial burden assessment in liver, spleen, and intestinal tissues
Transcriptomic and proteomic analyses:
RNA-Seq to compare gene expression profiles between wild-type and ΔaaeA strains
Quantitative proteomics to identify changes in protein expression
ChIP-Seq to identify regulatory networks affecting aaeA expression
Metabolomics to detect changes in bacterial or host metabolites
Similar methodologies have proven effective in studying other Salmonella virulence factors. For example, researchers investigating the SseB protein as a vaccine candidate used recombinant protein expression in E. coli, western blotting for immunoreactivity assessment, and mouse challenge models to evaluate protection against virulent Salmonella Enteritidis . Additionally, studies on the effector AvrA employed immunoblotting techniques and pathogenicity assessments to determine its role in Salmonella virulence .
To accurately measure AaeA-mediated efflux activity, researchers should consider the following techniques, each addressing different aspects of efflux pump function:
Fluorescent substrate accumulation/efflux assays:
Use fluorescent substrates (if available) or fluorescently labeled p-hydroxybenzoic acid derivatives
Monitor intracellular accumulation in wild-type versus ΔaaeA strains
Measure real-time efflux kinetics after energizing cells with glucose
Radioisotope-based transport assays:
Use radiolabeled substrates (e.g., 14C-labeled p-hydroxybenzoic acid)
Quantify uptake and efflux rates in membrane vesicles or whole cells
Compare transport kinetics between wild-type and mutant strains
Growth inhibition assays:
Determine minimum inhibitory concentrations (MICs) of known substrates
Generate dose-response curves for various potential substrates
Compare growth kinetics in the presence of toxic substrates
Direct measurement of substrate transport:
High-performance liquid chromatography (HPLC) to quantify substrate levels
Mass spectrometry to identify and quantify transported compounds
Nuclear magnetic resonance (NMR) spectroscopy for structural characterization of substrates
Membrane potential monitoring:
Use membrane potential-sensitive dyes to assess the energetics of transport
Determine the dependence of efflux on proton motive force or ATP
Reconstituted systems:
Reconstitute purified AaeA and AaeB into proteoliposomes
Measure transport activities in the controlled environment of artificial membranes
Assess the effects of membrane composition on transport efficiency
Research in E. coli has demonstrated that mutant strains lacking aaeA show hypersensitivity to p-hydroxybenzoic acid, confirming its role in efflux . Similar methodologies could be applied to study the Salmonella enteritidis AaeA protein, with appropriate controls and substrate selections based on the specific research questions being addressed.